— Know what they know.
Not Investment Advice

MEDP NASDAQ

Medpace Holdings, Inc.
1W: +8.2% 1M: +9.4% 3M: +15.2% YTD: +18.0% 1Y: +11.3% 3Y: +193.9% 5Y: +262.9%
$673.79
-2.98 (-0.44%)
Pre-Market: $665.00 (-8.79, -1.30%)
Weekly Expected Move ±5.1%
$601 $635 $669 $703 $738
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Strong Buy · Power 76 · $18.8B mcap · 23M float · 1.34% daily turnover · Short 58% of daily vol
Credit Risk of going bust: lower than 87% of companies Debt: 0.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.51 (down 99.9%), Medpace Holdings, Inc. would be worth roughly what it owes.
Total debt $146.0M against a stock market value of $18.85B.
Distance to default 12.17 (Merton model): prices to 2026-10-27, balance sheet 2026-09-30, debt counted $73.0M (short-term plus half of long-term), stock volatility 45.3%; Altman Z'' 0.91. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$2.0B -6.0% ▼
5Y CAGR: +7.3%
Total Liabilities
$1.5B +18.9% ▲
5Y CAGR: +21.0%
Shareholders Equity
$459M -44.4% ▼
5Y CAGR: -10.6%
Cash & Investments
$497M -25.8% ▼
5Y CAGR: +12.3%
Total Debt
$250M +67.5% ▲
5Y CAGR: +16.8%
Net Debt
-$247M +52.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$461M$28M$245M$669M$497M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$461M$28M$245M$669M$497M
Net Receivables$186M$253M$298M$296M$402M
Inventory$0$0$0$0$0
Other Current Assets$0$52M$50M$63M$90M
Total Current Assets$691M$334M$594M$1.0B$990M
Property, Plant & Equip.$223M$249M$265M$252M$249M
Goodwill & Intangibles$704M$700M$698M$697M$696M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$17M$21M$25M$22M$22M
Total Non-Current Assets$969M$1.0B$1.1B$1.1B$986M
Total Assets$1.7B$1.4B$1.7B$2.1B$2.0B
— Liabilities —
Accounts Payable$26M$33M$32M$33M$28M
Short-Term Debt$0$50M$0$23M$23M
Deferred Revenue$345M$463M$560M$711M$854M
Other Current Liabilities$85M$119M$116M$115M$358M
Total Current Liabilities$557M$803M$925M$1.1B$1.3B
Long-Term Debt$0$0$0$0$114M
Other Non-Current Liab.$18M$23M$28M$43M-$64M
Total Non-Current Liabilities$150M$163M$173M$171M$173M
Total Liabilities$707M$966M$1.1B$1.3B$1.5B
— Equity —
Common Stock$360K$309K$308K$306K$284K
Retained Earnings$235M-$360M-$222M$8M-$460M
Accumulated OCI-$5M-$12M-$10M-$15M-$5M
Total Stockholders Equity$953M$386M$559M$826M$459M
Total Liabilities & Equity$1.7B$1.4B$1.7B$2.1B$2.0B
— Key Metrics —
Total Debt$131M$189M$142M$150M$250M
Net Debt-$330M$161M-$103M-$520M-$247M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms